Thursday, March 2, 2017

"The patient voice is speaking with a pharma accent."

I'm shocked, shocked to discover that "at least 83% of the nation’s 104 largest patient advocacy groups take contributions from the drug, medical device and biotech industries, raising questions about whether they consistently put patients first."

Actually, we've known this for at least a decade, probably longer.  But it's good that the New England Journal of Medicine is finally catching up.

No comments:

Post a Comment